Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...

A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

Eli Lilly announced Tuesday that it is selling higher-dose vials ... "There’s likely to be some sticker shock for many, and whether they’ll be able to continue to afford the therapy remains to be seen ...

Compounding pharmacies aren’t surrendering their ability to create cheaper knockoff versions of Eli Lilly and Novo Nordisk ... Brunner added that there will be “sticker shock for many ...

With Novo Nordisk’s blockbuster drugs Wegovy and Ozempic back in stock, copycat versions are no longer allowed – for now.

Their compounded semaglutide is priced at less than $200 per month, which is a no-brainer for consumers compared to Wegovy's $1,000+ sticker price ... Nordisk (NVO) and Eli Lilly (LLY), the ...

Tirzepatide is the active ingredient in Eli Lilly’s weight loss drug Zepbound ... There’s likely to be some sticker shock for many, and whether they’ll be able to continue to afford the ...

In the case of Eli Lilly, they reported that the list price ... Yet the public experiences justifiable “sticker shock” at the steadily rising price of what is essentially a commodity drug ...

The Dartmouth Review is a bi-weekly conservative newspaper at Dartmouth College in Hanover, New Hampshire. It was founded in ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.